Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Ablation of cardiac myosin-binding protein-C accelerates contractile kinetics in engineered cardiac tissue.

de Lange WJ, Grimes AC, Hegge LF, Ralphe JC.

J Gen Physiol. 2013 Jan;141(1):73-84. doi: 10.1085/jgp.201210837.

2.

E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction.

De Lange WJ, Grimes AC, Hegge LF, Spring AM, Brost TM, Ralphe JC.

J Gen Physiol. 2013 Sep;142(3):241-55. doi: 10.1085/jgp.201311018.

3.

Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice.

Stöhr A, Friedrich FW, Flenner F, Geertz B, Eder A, Schaaf S, Hirt MN, Uebeler J, Schlossarek S, Carrier L, Hansen A, Eschenhagen T.

J Mol Cell Cardiol. 2013 Oct;63:189-98. doi: 10.1016/j.yjmcc.2013.07.011. Epub 2013 Jul 26.

4.

Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes.

Pohlmann L, Kröger I, Vignier N, Schlossarek S, Krämer E, Coirault C, Sultan KR, El-Armouche A, Winegrad S, Eschenhagen T, Carrier L.

Circ Res. 2007 Oct 26;101(9):928-38. Epub 2007 Sep 6.

5.

Neonatal mouse-derived engineered cardiac tissue: a novel model system for studying genetic heart disease.

de Lange WJ, Hegge LF, Grimes AC, Tong CW, Brost TM, Moss RL, Ralphe JC.

Circ Res. 2011 Jun 24;109(1):8-19. doi: 10.1161/CIRCRESAHA.111.242354. Epub 2011 May 12. Erratum in: Circ Res. 2012 May 25;110(11):e91.

6.

Phosphoregulation of Cardiac Inotropy via Myosin Binding Protein-C During Increased Pacing Frequency or β1-Adrenergic Stimulation.

Tong CW, Wu X, Liu Y, Rosas PC, Sadayappan S, Hudmon A, Muthuchamy M, Powers PA, Valdivia HH, Moss RL.

Circ Heart Fail. 2015 May;8(3):595-604. doi: 10.1161/CIRCHEARTFAILURE.114.001585. Epub 2015 Mar 4.

7.

Dissociation of structural and functional phenotypes in cardiac myosin-binding protein C conditional knockout mice.

Chen PP, Patel JR, Powers PA, Fitzsimons DP, Moss RL.

Circulation. 2012 Sep 4;126(10):1194-205. doi: 10.1161/CIRCULATIONAHA.111.089219. Epub 2012 Jul 24.

8.

Molecular effects of the myosin activator omecamtiv mecarbil on contractile properties of skinned myocardium lacking cardiac myosin binding protein-C.

Mamidi R, Gresham KS, Li A, dos Remedios CG, Stelzer JE.

J Mol Cell Cardiol. 2015 Aug;85:262-72. doi: 10.1016/j.yjmcc.2015.06.011. Epub 2015 Jun 20.

9.

Ablation of cardiac myosin-binding protein-C accelerates stretch activation in murine skinned myocardium.

Stelzer JE, Dunning SB, Moss RL.

Circ Res. 2006 May 12;98(9):1212-8. Epub 2006 Mar 30.

10.

Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy.

Barefield D, Kumar M, de Tombe PP, Sadayappan S.

Am J Physiol Heart Circ Physiol. 2014 Mar;306(6):H807-15. doi: 10.1152/ajpheart.00913.2013. Epub 2014 Jan 24.

11.

Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice.

Harris SP, Bartley CR, Hacker TA, McDonald KS, Douglas PS, Greaser ML, Powers PA, Moss RL.

Circ Res. 2002 Mar 22;90(5):594-601.

12.
13.

Ablation of myosin-binding protein-C accelerates force development in mouse myocardium.

Stelzer JE, Fitzsimons DP, Moss RL.

Biophys J. 2006 Jun 1;90(11):4119-27. Epub 2006 Mar 2.

14.

Control of in vivo left ventricular [correction] contraction/relaxation kinetics by myosin binding protein C: protein kinase A phosphorylation dependent and independent regulation.

Nagayama T, Takimoto E, Sadayappan S, Mudd JO, Seidman JG, Robbins J, Kass DA.

Circulation. 2007 Nov 20;116(21):2399-408. Epub 2007 Nov 5. Erratum in: Circulation. 2008 Jan 1/8;117(1):e11.

15.

Acceleration of crossbridge kinetics by protein kinase A phosphorylation of cardiac myosin binding protein C modulates cardiac function.

Tong CW, Stelzer JE, Greaser ML, Powers PA, Moss RL.

Circ Res. 2008 Oct 24;103(9):974-82. doi: 10.1161/CIRCRESAHA.108.177683. Epub 2008 Sep 18.

16.
17.

A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction.

Kuster DW, Govindan S, Springer TI, Martin JL, Finley NL, Sadayappan S.

J Biol Chem. 2015 Feb 27;290(9):5855-67. doi: 10.1074/jbc.M114.607911. Epub 2015 Jan 12.

18.

Binding of myosin binding protein-C to myosin subfragment S2 affects contractility independent of a tether mechanism.

Harris SP, Rostkova E, Gautel M, Moss RL.

Circ Res. 2004 Oct 29;95(9):930-6. Epub 2004 Oct 7.

19.

In vivo left ventricular functional capacity is compromised in cMyBP-C null mice.

Brickson S, Fitzsimons DP, Pereira L, Hacker T, Valdivia H, Moss RL.

Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1747-54. Epub 2006 Nov 22.

20.

Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice.

Barefield D, Kumar M, Gorham J, Seidman JG, Seidman CE, de Tombe PP, Sadayappan S.

J Mol Cell Cardiol. 2015 Feb;79:234-43. doi: 10.1016/j.yjmcc.2014.11.018. Epub 2014 Nov 25.

Items per page

Supplemental Content

Write to the Help Desk